Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters











Database
Language
Publication year range
3.
Ment Health Clin ; 12(4): 232-240, 2022 Aug.
Article in English | MEDLINE | ID: mdl-36071741

ABSTRACT

Introduction: Long-acting injectable antipsychotics (LAI-As) are important tools for the treatment of schizophrenia, yet they appear to be underutilized. This study will assess practitioner perceptions of LAI-As to elucidate reasons for underuse and uncover new avenues to increase appropriate use. Methods: An anonymous electronic survey was developed and actively distributed to behavioral health care practitioners (MD, DO, PA, NP, PharmD, RN, LCSW). Independent t testing and linear regression analysis was used to assess for interactions between survey responses and individual factors. Results: A total of 146 survey responses were collected from September 3, 2020 to March 17, 2021. On average, participants thought that LAI-As were slightly underutilized in practice. The mean estimated patient acceptance rate for LAI-A therapy was 38.6% ± 29.5% (range = 0%-100%). Participants who were <40 years of age and those with a psychiatric pharmacist at their practice site had significantly higher estimated acceptance rates. The highest-rated barriers to LAI-A use were related to negative patient attitudes, lack of patient education, and access issues (eg, transportation, cost). Respondent characteristics including age, gender identity, geographic location, practice setting, and the presence of a psychiatric pharmacist significantly influenced the perceived impact of these barriers. Discussion: Behavioral health practitioners generally believed that LAI-As were underused, and only one-third of their patients would be accepting of the therapy. Several barriers were perceived as frequently impacting LAI-A use, but these were reduced by the presence of a psychiatric pharmacist. Understanding practitioner perceptions can assist with increasing the use of LAI-As.

5.
J Hosp Med ; 5(7): E12-3, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20564527

ABSTRACT

Iliac vein compression syndrome (CS) is a rare cause of deep venous thrombosis. It is caused by an anatomic anomaly in which the right common iliac artery overlies the left common iliac vein causing mechanical compression. Subsequent endothelial changes within the vessels have the potential to spur thrombus formation. Aggressive diagnostic and therapeutic interventions must be implemented upon suspicion to avoid long-term complications. We report on a 19 year old male who presented with ICS. We discuss the clinical presentation, diagnosis, and current treatment options.


Subject(s)
Iliac Vein/pathology , Lower Extremity/pathology , Venous Thrombosis/etiology , Anticoagulants/therapeutic use , Clopidogrel , Constriction, Pathologic/complications , Constriction, Pathologic/pathology , Constriction, Pathologic/therapy , Heparin/therapeutic use , Humans , Lower Extremity/blood supply , Male , Platelet Aggregation Inhibitors/therapeutic use , Syndrome , Thrombectomy , Thrombolytic Therapy , Ticlopidine/analogs & derivatives , Ticlopidine/therapeutic use , Venous Thrombosis/pathology , Venous Thrombosis/therapy , Warfarin/therapeutic use , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL